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(1) Summary of key principles (2) Importance of partner notification (3) Aim (4) Statement development (5) Audience and care networks (6) Competency in partner notification (PN) practice (7) Offering PN (8) Infections for which PN should be offered and look-back intervals (9) (1) Summary of key principles † Healthcare workers (HCWs) providing partner notification (PN) should have documented competencies appropriate to the care given. These competencies should correspond to the content and methods described in the Society of Sexual Health Advisers (SSHA) Competency Framework for Sexual Health Adviser; † All services involved in managing sexually transmitted infections (STIs) should follow the NICE Guidance on one-to-one interventions to reduce transmission of STIs; detection, reducing onward infection and re-infection, and the complications of infection. PN also involves providing other sexual health needs, including managing risk behaviour and ethical issues.
Re-infection with chlamydial and gonorrhoeal infection is common, 1, 2 underscoring the importance of PN for the care of both people with infection and their sexual partners. A Cochrane review has shown moderately strong evidence for effectiveness of PN in providing access to care for contacts of STIs, including HIV infection. 3 Another systematic review has shown that interventions supplementing patient referral for STIs improve PN outcomes. 4 The major contribution of PN to the cost effectiveness of the UK National Screening Programme has also been demonstrated. 5 
(3) Aim
The aim of this Statement is to outline general principles on good PN practice, and to provide a resource for quality improvement activity. In particular, the Statement aims to promote consistency in the use of terms and measurements in order to improve the quality of data collected for audits.
Where appropriate, future BASHH Clinical Effectiveness Group (CEG) guidelines (including in the 'auditable outcome measures' sections) and National Audit Group (NAG) audit questionnaires should refer to this Statement for recommended practice and performance measurement for PN. This Statement is not intended to provide the operational detail involved in PN practice, which is described in the SSHA Manual (and which is currently under review).
(4) Statement development
There are currently many different statements relating to PN process outcomes in the BASHH CEG Guidelines. This was discussed in a BASHH Clinical Standards Unit (CSU) meeting in January 2011, when it was decided to produce a statement on PN practice that would support a set of uniform PN process outcome measures that could be referred to in future BASHH CEG Guidelines and by BASHH NAG audit questionnaires. Additionally, it was agreed that the results of the BASHH 2011 audit against the BASHH Medical Foundation for AIDS and Sexual Health (MedFASH) Standards 7 should be used to update the existing chlamydial PN process outcome measures 8 (which were also based on performance data in audits). An agreed early version of the Statement was produced by the BASHH NAG, CEG and CSU and posted during October to November 2011 on the BASHH CEG public web page for consultation. After use of the consultation feedback, and consultation with the UK Society of Sexual Health Advisers and experts in the field, further drafts were produced and final version was agreed. This included additional sections, including legal, health protection and safeguarding issues.
The recommendations in this document are presented as a statement because, unlike a guideline, the recommendations made are not mainly based on empirical evidence, but on accepted practice, current performance (with regard to the justifications for the updated chlamydial PN performance standards), and other guidance, including the look-back intervals stated in BASHH guidelines. However, there is lack of evidence to support the use of specific look-back intervals. For example, although most positive chlamydial contacts have last had sex with index chlamydial index cases in the three months before the latter's diagnosis, important numbers of positive contacts have had sexual contact (much) earlier than this interval. 13, 14 Hence, these look-back intervals are for guidance and every case should be individually assessed on the basis of the sexual history, risk assessment and particular circumstances. There may be benefit, if feasible, in offering PN for some contacts earlier than these look-back intervals (including to at least the last sexual contact), and but also justification for not offering PN within these specified intervals. The use of look-back intervals should be appropriately documented. For screening of non-sexual contacts, including household contacts, who may be at risk, discuss with the CCDC ‡ or equivalent
The infectious period for acute hepatitis C is from two weeks before the onset of jaundice. However, usually there is no jaundice or history to suggest acute infection, and the look-back period for PN is to the likely time of infection (e.g. blood transfusion or first sharing of injection equipment), although this may not be possible for long look-back intervals. However, PN should be offered in two situations only, where: † There was vaginal or peno-anal sexual contact and either the index case and/or the sexual contact(s) have HIV infection † Sharing of injection equipment occurred during the period in which the index case is thought to have been infectious
No
Appropriate repeat serological testing of these contacts should be offered Sexual transmission of HCV through heterosexual sexual contact is uncommon if both the index case and sexual contacts do not have HIV infection, and PN is not recommended for this group. Check that children born to women with hepatitis C infection have been tested for hepatitis C infection in accordance with nationally accepted guidance. Although there is no evidence-based guidance currently available, in a recent multi-disciplinary meeting 21 the following were agreed: † HIV PN should be initiated as soon as possible, and, by four weeks after a positive HIV test result, agreed contact actions (see Section 10) and timelines should be documented. Any outcomes of PN already carried out should also be documented at this time † Consensus that PN should be resolved (see Section 11) by three months, but that if PN is still unresolved by this time it should be continued, with clear timelines, as successful PN outcomes have been reported up to 12 months after a positive HIV test
LGV infection For cases with symptoms: all contacts since and in the four weeks prior to the onset of symptoms
Yes
For cases without symptoms: all contacts in the three months prior to LGV detection (Continued) 
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Infection Look-back intervals for partner notification
Epidemiological treatment
Non-specific (non-chlamydial, non-gonococcal) urethritis in men Male index cases with symptoms attributable to urethritis: all contacts since, and in the four weeks prior to, the onset of symptoms Ã Yes (Screening of men, without clinical features suggesting urethritis, by microscopy is not recommended practice, and therefore PN is not recommended for this group) Pelvic inflammatory disease Use the look-back intervals for chlamydial infection or gonorrhoea, if these are detected. If these infections are not detected, the look-back interval is for all contacts since, and in the 6 months prior to, the onset of symptoms Ã,ÃÃ
Yes
Phthirus pubis infestation All contacts since, and in the three months prior to, the onset of symptoms Yes -current sexual partner(s) only
Scabies infestation All contacts (including non sexual contacts: those with prolonged skin-to-skin contact, bed and clothes sharing, and household contacts) since, and in the two months prior to, the onset of symptoms PN should be offered at follow-up visits when there are new sexual contacts, and to discuss re-testing of current partners and testing of children, where appropriate ÃÃ The six-month look-back interval for PID is given arbitrarily on the basis that Mycoplasma genitalium may cause disease in women and be asymptomatically carried in men and women for an unknown period. 24 Also, false-negative chlamydial nucleic acid amplification tests, as well as discordant chlamydial test results, and different rates of spontaneous clearance of chlamydial infection, between sexual partners, are possible.
25
} Trichomonal infection appears to resolve spontaneously in most men, usually within two weeks, with detection rates in men decreasing with increasing time from last sexual contact with female index cases. However, prolonged asymptomatic carriage has been demonstrated in some men.
-28
(10) Agreed contact actions When the first PN discussion takes place, a plan should be agreed with the index patient, and documented, about which contacts to contact and, if so, how this should be done. All contacts in the appropriate look-back interval should be included. All contacts include those considered not traceable, as well as those who had attended a service for management of the relevant infection before the index patient was first seen. In deciding whether a contact is traceable, appropriate use of all information sources should be considered. Possible contact actions are: patient, provider or contract methods of PN (see p. 20 of the Manual for Sexual Health Advisers 6 for definitions of these methods), or no action. No action is appropriate when a contact is considered not traceable, or a contact has been verified as already seen. Not traceable may include contacts who cannot be contacted by patient, provider or contract methods of PN because of lack of information, or because of patient preference or welfare needs not to involve a contact. However, there may be circumstances requiring a "best interests" obligation to break confidentiality (e.g. when the health of another person is at risk), when local policies should be followed.
These recommendations should be used together with the operational detail provided in the SSHA Manual for Sexual Health Advisers 6 and the BASHH UK National guidelines on undertaking consultations requiring sexual history taking, 29 as well as the soon-to-be-published SSHA Competencies.
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(11) PN resolution PN resolution (the outcome of an agreed contact action) for each contact should be documented within four weeks of the date of the first PN discussion, but see the comments about HIV PN in the table in Section 9. Documentation about outcomes may include the attendance of a contact at a service for the management of the infection, testing for the relevant infection, the result of testing and appropriate treatment of a contact. A record should be made of whether this is based on index case report, or verified by a HCW. Verified means confirming contact attendance by checking records in your own service, or by contacting other services where contacts may have attended.
Exceptions to achieving documentation of PN outcomes by four weeks include prioritizing urgent health needs (e.g. in an ill patient or a patient with multiple health problems), as well as disclosure issues (e.g. with regard to the management of people with HIV infection). These exceptions, as well as an agreed time frame for resolution, should be clearly documented. 10 and by the UK National Chlamydial Screening Programme. 35 The previous standard is based on a number of different audits and surveys, which used various methodologies, and all of which are more than ten years old, and where process outcomes for index case-reported and HCW-verified contact events could not be differentiated. Additionally, the 2011 BASHH Audit against the Key Performance Indicators in the BASHH MedFASH STI Management Standards (STIMS) Audit 37 used a uniform methodology and provides a large amount of current data on PN performance that allows updating of the previous standard, including the proposal of new standards for HCW-verified contact attendance. Performance has changed since the data supporting the previous standard were published: in the STIMS Audit index case-reported contact attendance for Level 3 clinics in London is now higher than that for Level 3 clinics outside London (see below). Performance data from the STIMS Audit, on which the updated PN standards are based, are summarized in the table below:
The 0.6 standard for index case-reported contact attendance has remained the same for clinics other than large city clinics (London, Birmingham and Manchester). There are three main changes: † Clinics are grouped as outside London or London clinics, instead of other and London/large city. The original grouping in the review that set the previous PN standard for chlamydial infection 8 was 'London/large city' (qualified as London, Birmingham and Manchester) and 'Other,' since referred to as 'large conurbation' and 'elsewhere' in the STIMS. The STIMS Audit reported on performance for clinics in London and clinics outside London. The reason for this was that there is lack of current PN performance data to support grouping particular large cities with London, and there are other large cities with similar or greater population densities compared to Birmingham and Manchester. 36 More recent chlamydial PN performance in three large genitourinary medicine clinics in the West Midlands is closer to the 0.6 standard. 37 Additionally, more recent national audits have presented London chlamydial PN performance data separately. 38, 39 In the STIMS Audit, the four participating clinics in Birmingham and Manchester had a median index case-reported contact attendance of 0.49 contacts per index case, lower than the median for the London clinics and closer to that of other clinics outside London. † The standard for index case-reported contact attendance for large city clinics, including London clinics, is now 0.6. This is based on performance and acceptability factors. The previous standard for index case-reported contact attendance for London clinics was 0.4, but the median performance for London clinics in the STIMS Audit for this measure was 0.8. Rather than propose a new standard which is double that of the previous standard, 0.6 is recommended as a standard that would be more acceptable. A recent publication on PN performance from a London clinic supports the 0.6 standard (with 64% of patients with chlamydia having at least one partner treated within 4 weeks, mainly based on patient report and a well-designed electronic data recording system). 40 † Measurement of verified contact attendance is now recommended, and the standard for verified contact attendance is the same for outside London and London clinics. Verified contact attendance reflects best practice in PN because it allows ascertainment of whether contacts were actually appropriately seen, and provides a reliable measure of the Public Health impact of PN work. However, verifying contact attendance requires more support and resources, including dedicated time in job plans and administrative support for HCWs to do this work, as well as support from managers and commissioners.
The outside-London standard for verified contact attendance is at least 0.4 contacts. This is based on performance and acceptability factors. Even though median verification performance for clinics outside London is 0.6, a lower standard at 0.4 is recommended. This is because verification may be generally considered to less easy to achieve than patient-reported contact attendance, and the 0.4 standard may be more acceptable to clinics outside London. The HPA defines an STI outbreak/incident as one of the following: † An observed number of cases that is greater than expected over a defined time period in a given community. This could amount to a small number of cases; † Linked cases that are of public health significance; † A situation that requires the re-organization of services or development of additional resources to diagnose and manage cases.
The Guidance also emphasizes the need for local clinicians to review clinical data in order to detect and act on outbreaks. Where a potential outbreak or incident has been identified, the HPU can support the management of the outbreak/ incident, including liaison with adjacent localities as appropriate. Typically there three phases of outbreak/incident control: † Phase 1 (Preliminary): an incident team is convened to determine whether a problem exists and, if so, what action to take next; † Phase 2 (Control): An outbreak control team (OCT) develops and implements strategies to limit onward transmission of infection, using a variety of investigation and control approaches; † Phase 3 (Evaluation): a process evaluation, and assessment of success using primary outcome measures is undertaken, with audit as necessary.
An example of an incident jointly managed in this way is described in a recent publication. 44 Currently, there is reliance on performance data from audits to recommend outcome standards. Also, the available audit data mainly provide patient-centred process outcomes (e.g. contacts seen per index case) that conceal the variability in transmission likelihoods associated with different types of contact (e.g. live-in, regular and casual). The measurement of PN process outcomes related to contact-centred outcomes, and epidemiological measures of transmission interruption, may be a better estimation of the impact, and optimal use, of resources for PN, as suggested in a study by Mercer et al. 45 Further work is needed on the epidemiological approach to measuring PN impact on local populations and setting PN performance standards. 46 code C4, whose attendance at a Level 1, 2 or 3 sexual health service was documented as reported by the index case, or by an HCW, within four weeks of the date of the first PN discussion, and during a specified interval. Denominator: The total number of index cases with SHHAPT code C4 managed by the service during the same interval. Verified contact attendance Numerator: The total number of contacts, of index cases with SHHAPT code C4, whose attendance at a Level 1, 2 or 3 sexual health service was documented as verified by an HCW, within four weeks of the date of the first PN discussion, and during a specified interval. Denominator: The total number of index cases with SHHAPT code C4 managed by the service during the same interval. The C4 SHHAPT code should be used only once per patient episode, so it is important to appropriately close episodes in registration systems to allow for cases re-presenting with new chlamydial infection to be included in the numerator. That is, cases thought to be newly infected after a previous episode of chlamydia should be regarded as a new GUM episode and coded accordingly. Please refer to the Genitourinary Medicine Clinic Activity Dataset Guidance about correct use of the C4 code. 46 If C4 is used more than once in an audit interval, only contacts thought to be involved in the new episode should be counted. When counting the number of index-reported contact attendances, include: † Contacts with attendance verified by an HCW, even if there is no record of attendance reported by an index case. Many contacts with verified attendance will also have reported attendance. However, it may be possible to record that a contact was verified as having attended the same clinic (or another clinic), without this being reported by an index case, provided that sufficient baseline contact information was obtained. Counting verified attendance in with reported attendance is intended to facilitate the counting of contacts for the purpose of audits and improve consistency between clinics. This means that the number of indexreported contacts should be greater than the number of verified contacts; † Contacts reported as attending by an HCW. An HCW may have received information, other than from the index case, that a contact has attended a service managing STIs, without verifying this by contacting that service.
It may not be possible to verify contact attendance, e.g. when there is no information about where a contact may have attended. However, as a minimum, a clinic's own records should be checked for contact attendance. Also, please see the comments above in the future developments section (Section 18).
